What You Should Know:
- Quilt Health, a digital health company dedicated to bridging gaps in treatment access for complex diseases secures $6M in seed funding round, bringing its total funding to $8M. The round was led by MaC Venture Capital and Underscore Ventures, with participation from Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators.
- Founded with an initial focus on sickle cell disease, the company plans to use the new capital to rapidly expand into
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton
What You Should Know:
- Robotics startup Wandercraft has begun clinical trials for its new Personal Exoskeleton.
- Founded by Nicolas Simon, whose siblings face mobility challenges from Charcot-Marie-Tooth disease, Wandercraft aims to help individuals with spinal cord injuries, stroke, and other severe neuromuscular disorders stand and walk again using advanced robotics and artificial intelligence.
From Rehabilitation Tool to Personal Mobility
Wandercraft is already known
Read More
Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment
What You Should Know:
- Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials.
- The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.
Enhance
Read More
Simplifying Clinical Trials: Addressing Technology Challenges for Site Teams
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel valued as partners in the processes and approaches to care that impact their health. Clinical trial sponsors are keenly aware that, to do so, the use of advanced clinical technologies, including decentralized solutions, has been necessary to improve patient experience and accelerate drug development. But as sponsors implement multiple
Read More
Medidata Integrates UK Costing Data into Grants Manager, Streamlining Clinical Trial Budgeting
What You Should Know:
- Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, today announced the integration of data from the UK interactive Costing Tool (iCT) into its Grants Manager platform.
- The collaboration with the National Institute for Health and Care Research (NIHR) provides life sciences organizations with a streamlined and standardized approach to clinical trial budgeting, enhancing efficiency and transparency in research
Read More
Flatiron Health and Exact Sciences Partner to Accelerate Clinical Evidence Generation for MRD Testing in Oncology
What You Should Know:
- Flatiron Health, a leading technology company focused on improving cancer care announced a strategic partnership with Exact Sciences, a pioneer in cancer screening and diagnostics to accelerate clinical evidence generation for Exact Sciences' molecular residual disease (MRD) test, Oncodetect™.
- The collaboration will leverage Flatiron's innovative clinical research platform and extensive network of community oncology practices to study the test's performance
Read More
Medidata and Cognizant Expand Partnership to Accelerate Clinical Trial Development
What You Should Know:
- Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata's life sciences clients and expand the strategic alliance partnership.
- Over the years, the companies have partnered to deliver a comprehensive framework supporting life sciences clients, emphasizing customer success, patient service desk, implementation,
Read More
Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395
What You Should Know:
- Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced solid tumors.
- OKN4395 represents a novel approach to cancer treatment by targeting multiple immunosuppressive pathways simultaneously.
OKN4395 Background
OKN4395 is a first-in-class asset that selectively inhibits three
Read More
ActiGraph and Hyfe Launch AI-Powered Cough Detection for Clinical Trials
What You Should Know:
- ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.
- This new combined solution allows researchers to leverage Hyfe’s validated cough detection algorithms alongside ActiGraph’s industry-leading digital measures for
Read More
Inato Launches AI-Powered Patient Pre-Screening to Reduce Site Burden and Accelerate Enrollment
What You Should Know:
- Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
- The company’s latest advancement integrates a series of artificial intelligence (AI) models into a unified agent that quickly and securely reviews patient records and assesses eligibility, transforming a
Read More
